These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 29452038)
1. Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Summary. J Oncol Pract; 2009 May; 5(3):127-129. PubMed ID: 29452038 [TBL] [Abstract][Full Text] [Related]
2. Do alpha-reductase inhibitors prevent prostate cancer? 2008 practice guideline from the American society of clinical oncology and American urological association. Thüer D; Pfister D; Epplen R; Brehmer B; Heidenreich A Pol Arch Med Wewn; 2009 Oct; 119(10):648-53. PubMed ID: 19847141 [TBL] [Abstract][Full Text] [Related]
3. Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. Kramer BS; Hagerty KL; Justman S; Somerfield MR; Albertsen PC; Blot WJ; Carter HB; Costantino JP; Epstein JI; Godley PA; Harris RP; Wilt TJ; Wittes J; Zon R; Schellhammer P; J Urol; 2009 Apr; 181(4):1642-57. PubMed ID: 19249063 [TBL] [Abstract][Full Text] [Related]
4. Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline. Bekelman JE; Rumble RB; Chen RC; Pisansky TM; Finelli A; Feifer A; Nguyen PL; Loblaw DA; Tagawa ST; Gillessen S; Morgan TM; Liu G; Vapiwala N; Haluschak JJ; Stephenson A; Touijer K; Kungel T; Freedland SJ J Clin Oncol; 2018 Nov; 36(32):3251-3258. PubMed ID: 30183466 [TBL] [Abstract][Full Text] [Related]
5. Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. Kramer BS; Hagerty KL; Justman S; Somerfield MR; Albertsen PC; Blot WJ; Ballentine Carter H; Costantino JP; Epstein JI; Godley PA; Harris RP; Wilt TJ; Wittes J; Zon R; Schellhammer P; ; J Clin Oncol; 2009 Mar; 27(9):1502-16. PubMed ID: 19252137 [TBL] [Abstract][Full Text] [Related]
6. Words of wisdom. Re: Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 clinical practice guideline. Kramer BS, Hagerty KL, Justman S, et al. Messing E Eur Urol; 2009 Sep; 56(3):572. PubMed ID: 19824152 [No Abstract] [Full Text] [Related]
7. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914 [TBL] [Abstract][Full Text] [Related]
8. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ; J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455 [TBL] [Abstract][Full Text] [Related]
9. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. Cookson MS; Aus G; Burnett AL; Canby-Hagino ED; D'Amico AV; Dmochowski RR; Eton DT; Forman JD; Goldenberg SL; Hernandez J; Higano CS; Kraus SR; Moul JW; Tangen C; Thrasher JB; Thompson I J Urol; 2007 Feb; 177(2):540-5. PubMed ID: 17222629 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. Resnick MJ; Lacchetti C; Bergman J; Hauke RJ; Hoffman KE; Kungel TM; Morgans AK; Penson DF J Clin Oncol; 2015 Mar; 33(9):1078-85. PubMed ID: 25667275 [TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer. Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI; J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542 [TBL] [Abstract][Full Text] [Related]
12. [Role of 5 alpha-reductase inhibitors in the chemoprevention of prostate cancer]. An C; Xu T; Wang XF Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):582-6. PubMed ID: 22338147 [TBL] [Abstract][Full Text] [Related]
13. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. Sulman EP; Ismaila N; Armstrong TS; Tsien C; Batchelor TT; Cloughesy T; Galanis E; Gilbert M; Gondi V; Lovely M; Mehta M; Mumber MP; Sloan A; Chang SM J Clin Oncol; 2017 Jan; 35(3):361-369. PubMed ID: 27893327 [TBL] [Abstract][Full Text] [Related]
14. Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology. Bennett CL; Weeks JA; Somerfield MR; Feinglass J; Smith TJ J Clin Oncol; 1999 Nov; 17(11):3676-81. PubMed ID: 10550166 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline. Rudin CM; Ismaila N; Hann CL; Malhotra N; Movsas B; Norris K; Pietanza MC; Ramalingam SS; Turrisi AT; Giaccone G J Clin Oncol; 2015 Dec; 33(34):4106-11. PubMed ID: 26351333 [TBL] [Abstract][Full Text] [Related]
16. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW J Clin Oncol; 2015 Mar; 33(8):952-63. PubMed ID: 25572671 [TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology clinical practice guidelines: opportunities and challenges. Somerfield MR; Einhaus K; Hagerty KL; Brouwers MC; Seidenfeld J; Lyman GH; J Clin Oncol; 2008 Aug; 26(24):4022-6. PubMed ID: 18711193 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines. Djulbegovic B Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920 [TBL] [Abstract][Full Text] [Related]